BVXV stock closed at $4.15 and is up $0.41 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.
BVXV has a poor overall score of 5 meaning the stock holds a better value than just 5% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock.
BVXV gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Biondvax Pharmaceuticals Ltd - ADR currently has the 114th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.
Biondvax Pharmaceuticals Ltd - ADR's Overall and Short-Term Technical score paint a poor picture for BVXV's recent trading patterns and forecasted price.
Click Here to get the full Stock Score Report on Biondvax Pharmaceuticals Ltd - ADR (BVXV) Stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
